Excalibur Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.26M | Buy |
151,843
+963
| +0.6% | +$25.6K | 1.53% | 14 |
|
|
2025
Q4 | $3.76M | Buy |
150,880
+5,212
| +4% | +$131K | 1.35% | 15 |
|
|
2025
Q3 | $3.71M | Sell |
145,668
-4,379
| -3% | -$108K | 1.35% | 17 |
|
|
2025
Q2 | $3.64M | Sell |
150,047
-1,232
| -0.8% | -$28.7K | 1.36% | 16 |
|
|
2025
Q1 | $3.83M | Sell |
151,279
-2,357
| -2% | -$61.7K | 1.51% | 13 |
|
|
2024
Q4 | $4.08M | Sell |
153,636
-8,742
| -5% | -$237K | 1.62% | 11 |
|
|
2024
Q3 | $4.7M | Sell |
162,378
-1,958
| -1% | -$57.1K | 1.79% | 9 |
|
|
2024
Q2 | $4.6M | Buy |
164,336
+3,090
| +2% | +$85.1K | 1.88% | 9 |
|
|
2024
Q1 | $4.47M | Buy |
161,246
+3,026
| +2% | +$84K | 1.89% | 9 |
|
|
2023
Q4 | $4.56M | Sell |
158,220
-30
| -0% | -$907 | 2.14% | 8 |
|
|
2023
Q3 | $5.25M | Buy |
158,250
+3,878
| +3% | +$137K | 2.73% | 7 |
|
|
2023
Q2 | $5.66M | Buy |
154,372
+770
| +0.5% | +$30K | 2.88% | 6 |
|
|
2023
Q1 | $6.27M | Sell |
153,602
-26
| -0% | -$1.12K | 3.25% | 5 |
|
|
2022
Q4 | $7.87M | Sell |
153,628
-643
| -0.4% | -$30.8K | 4.11% | 2 |
|
|
2022
Q3 | $6.75M | Buy |
154,271
+1,476
| +1% | +$71.7K | 3.78% | 4 |
|
|
2022
Q2 | $8.01M | Sell |
152,795
-2,143
| -1% | -$109K | 4.17% | 3 |
|
|
2022
Q1 | $8.02M | Sell |
154,938
-877
| -0.6% | -$45.5K | 3.48% | 4 |
|
|
2021
Q4 | $9.2M | Sell |
155,815
-1,211
| -0.8% | -$60K | 3.71% | 4 |
|
|
2021
Q3 | $6.75M | Sell |
157,026
-2,777
| -2% | -$123K | 2.96% | 6 |
|
|
2021
Q2 | $6.26M | Buy |
159,803
+2,931
| +2% | +$114K | 2.83% | 9 |
|
|
2021
Q1 | $5.68M | Buy |
156,872
+5,191
| +3% | +$184K | 2.8% | 9 |
|
|
2020
Q4 | $5.58M | Sell |
151,681
-12,143
| -7% | -$445K | 3% | 8 |
|
|
2020
Q3 | $5.7M | Sell |
163,824
-9,760
| -6% | -$342K | 3.46% | 7 |
|
|
2020
Q2 | $5.38M | Buy |
173,584
+2,879
| +2% | +$97.8K | 3.59% | 7 |
|
|
2020
Q1 | $5.29M | Buy |
170,705
+7,033
| +4% | +$240K | 4.08% | 7 |
|
|
2019
Q4 | $6.08M | Sell |
163,672
-697
| -0.4% | -$24.8K | 3.98% | 7 |
|
|
2019
Q3 | $5.6M | Buy |
164,369
+5,609
| +4% | +$204K | 5.03% | 4 |
|
|
2019
Q2 | $6.53M | Sell |
158,760
-4,626
| -3% | -$184K | 6.01% | 3 |
|
|
2019
Q1 | $6.58M | Sell |
163,386
-2,065
| -1% | -$82.7K | 6.21% | 2 |
|
|
2018
Q4 | $6.85M | Sell |
165,451
-4,943
| -3% | -$205K | 6.92% | 2 |
|
|
2018
Q3 | $7.13M | Sell |
170,394
-10,324
| -6% | -$397K | 6.09% | 2 |
|
|
2018
Q2 | $6.22M | Sell |
180,718
-1,942
| -1% | -$66.4K | 4.95% | 4 |
|
|
2018
Q1 | $6.15M | Buy |
182,660
+725
| +0.4% | +$24.9K | 5% | 5 |
|
|
2017
Q4 | $6.25M | Sell |
181,935
-3,837
| -2% | -$131K | 5.25% | 5 |
|
|
2017
Q3 | $6.29M | Sell |
185,772
-3,968
| -2% | -$128K | 5.35% | 5 |
|
|
2017
Q2 | $6.05M | Sell |
189,740
-1,605
| -0.8% | -$50.6K | 5.42% | 5 |
|
|
2017
Q1 | $6.21M | Buy |
191,345
+2,454
| +1% | +$77.4K | 5.53% | 4 |
|
|
2016
Q4 | $5.82M | Buy |
188,891
+2,483
| +1% | +$75.8K | 5.3% | 6 |
|
|
2016
Q3 | $5.99M | Sell |
186,408
-9,708
| -5% | -$325K | 5.68% | 5 |
|
|
2016
Q2 | $6.55M | Sell |
196,116
-1,112
| -0.6% | -$35.5K | 5.63% | 5 |
|
|
2016
Q1 | $5.55M | Buy |
197,228
+330
| +0.2% | +$9.43K | 4.97% | 6 |
|
|
2015
Q4 | $6.03M | Sell |
196,898
-1,723
| -0.9% | -$54.2K | 5.61% | 5 |
|
|
2015
Q3 | $5.92M | Buy |
198,621
+4,975
| +3% | +$160K | 5.92% | 5 |
|
|
2015
Q2 | $6.16M | Buy |
193,646
+4,198
| +2% | +$137K | 5.76% | 5 |
|
|
2015
Q1 | $6.25M | Sell |
189,448
-12,379
| -6% | -$394K | 6.05% | 5 |
|
|
2014
Q4 | $5.96M | Sell |
201,827
-3,177
| -2% | -$91.1K | 6.01% | 5 |
|
|
2014
Q3 | $5.75M | Buy |
205,004
+1,305
| +0.6% | +$36.6K | 5.91% | 5 |
|
|
2014
Q2 | $5.74M | Buy |
203,699
+5,507
| +3% | +$157K | 5.99% | 5 |
|
|
2014
Q1 | $6.04M | Sell |
198,192
-6,693
| -3% | -$200K | 6.62% | 5 |
|
|
2013
Q4 | $5.95M | Sell |
204,885
-3,578
| -2% | -$104K | 6.49% | 5 |
|
|
2013
Q3 | $5.68M | Buy |
208,463
+8,980
| +5% | +$244K | 6.67% | 5 |
|
|
2013
Q2 | $5.3M | Buy |
+199,483
| New | +$5.51M | 6.58% | 5 |
|
Other funds holding PFE
VCM
VPM
Excalibur Management's PFE Position: Q1 2026 in Review
Excalibur Management increased its Pfizer (PFE) stake by 0.64% in Q1 2026, buying an estimated $25.6K and bringing the position to 151,843 shares worth $4.26M. The position accounts for 1.53% of the portfolio, ranked #14.
Excalibur Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.2M in Q4 2021. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Excalibur Management held 151,843 shares of Pfizer worth $4.26M as of Q1 2026.
- Excalibur Management bought 963 Pfizer shares in Q1 2026, an estimated $25.6K.
- Pfizer made up 1.53% of Excalibur Management's portfolio in Q1 2026, its #14 holding.
- Excalibur Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Excalibur Management's Pfizer position peaked at $9.2M in Q4 2021.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Excalibur Management's 13F filing for Q1 2026, filed 5 May 2026.